BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or BPC157 Dosing Recommendations by Weight TikTok Stable Gastric Pentadecapeptide BPC 157 Therapy for Monocrotaline Induced Pulmonary Hypertension in Rats Leads to Prevention and Reversal Stomach perforation induced general occlusion occlusion like syndrome and stable gastric pentadecapeptide BPC 157 therapy effect BPC 157 Dosage: A Complete Guide Dr. Rogers Centers.com Most people who talk about side effects from BPC 157 dont realize the problem isnt the peptide itself. The issue is that theyre getting unsterile, contaminated products from low quality research